Por: CNBC Health February 16, 2023
Moderna CEO, Stephane Bancel attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on December 05, 2019 in New York City.Steven Ferdman Getty Images CEO Stéphane Bancel will testify before the Senate health committee in March over the company's price for its vaccine when the shots are sold on the private market.Sen. Bernie Sanders, chairman of the health panel, confirmed in a statement on Wednesday that Bancel would appear at... + full article
MarketWatch USA Business January 18, 2023
(ticker: MRNA) said Tuesday its experimental messenger RNA-based RSV vaccine, known as mRNA-1345, was 83.7% effective at preventing less severe disease in adults aged 60 and above, and 82.4% effective at preventing more severe disease. The company only released topline results,... + más
GSK vaccine for older adults granted FDA priority review | Fox Business
Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC
The Boston Globe USA Business January 10, 2023
Moderna is looking for potential approval of two new vaccines this year to help compensate for waning sales of its COVID-19 shot, according to chief executive Stephane Bancel.Sales of the COVID vaccine, Spikevax, will be at least $5 billion this year, a figure that could rise as... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
CNBC USA Health January 10, 2023
U.S. Senator Bernie Sanders (I-VT) is trailed by reporters as he arrives for the weekly Democratic caucus luncheon at the U.S. Capitol in Washington, November 29, 2022.Jonathan Ernst ReutersSen. Bernie Sanders on Tuesday urged Moderna not to quadruple the price of its Covid-19... + más
Ars Technica USA Science January 10, 2023
Navigate Filter by topic Settings Front page layout Site theme - Jan 10, 2023 7:21 pm UTC / Moderna CEO Stephane Bancel during a Bloomberg Television interview on the closing day of the World Economic Forum in Davos, Switzerland, on May 26, 2022. Share this story Moderna is... + más
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |